Related Experiment Video
Updated: Dec 16, 2025

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study
Wen-Qiang Wei1, Chang-Qing Hao2, Chen-Tao Guan3
1National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Increasing grades of esophageal squamous dysplasia significantly elevate the risk of esophageal squamous cell carcinoma (ESCC). This study informs targeted screening and treatment strategies for ESCC in high-risk Chinese populations.
Area of Science:
- Gastroenterology
- Oncology
- Epidemiology
Background:
- Limited data exist on the association between esophageal histological lesions and esophageal squamous cell carcinoma (ESCC) risk in general populations.
- Understanding these associations is crucial for developing effective screening guidelines, particularly in high-risk regions like China.
Purpose of the Study:
- To investigate the association between esophageal histological lesions and the risk of ESCC incidence and mortality.
- To inform future ESCC screening guidelines in China based on findings in a large general population.
Main Methods:
- A cohort of 21,111 participants aged 40-69 years from high-risk areas in China underwent endoscopic screening.
- Participants were followed up through 2016, with cumulative incidence and mortality rates of ESCC calculated.
- Cox proportional hazards models were used to assess hazard ratios for ESCC, considering age and sex.
Main Results:
- 143 new ESCC cases (0.68%) and 62 ESCC deaths (0.29%) were identified over a median follow-up of 8.5 years.
- Increasing grades of squamous dysplasia were strongly associated with increased ESCC incidence and mortality.
- Cumulative ESCC incidence rates were 1.4% for mild dysplasia, 4.5% for moderate dysplasia, and 15.5% for severe dysplasia/carcinoma in situ.
Conclusions:
- The study confirms a dose-response relationship between squamous dysplasia grade and ESCC risk.
- Severe dysplasia and carcinoma in situ warrant clinical treatment.
- Recommendations include therapeutic intervention for worrisome moderate dysplasia, postponing initial screening to age 50, and adjusting surveillance intervals for mild and moderate dysplasia.
Related Concept Videos
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Cancer Prevention
Some...

